Long-term Allergen-specific Immunotherapy Results in Allergic Rhinitis

Kohei Honda; Chikara Asaka; Naoko Fukui; Eiko Ito; Kazuo Ishikawa

doi:10.5631/jibirinsuppl.129.64

Festschrift for Professor Kazuo Ishikawa In Honor of 10 Years of Chairmanship, Department of Otorhinolaryngology-Head and Neck Surgery, Akita University Graduate School of Medicine

Long-term Allergen-specific Immunotherapy Results in Allergic Rhinitis

Kohei Honda, Chikara Asaka, Naoko Fukui, Eiko Ito, Kazuo Ishikawa

Author information

Keywords: immunotherapy, allergic rhinitis, asthma

JOURNAL RESTRICTED ACCESS

2010 Volume 129 Pages 64-67

DOI https://doi.org/10.5631/jibirinsuppl.129.64

Details

Abstract

Allergen immunotherapy is a global effort in the managing allergic rhinitis. Using questionnaires, we clarified long-term prognosis in children with allergic rhinitis due to house dust. Nasal symptoms improved in 42.1% treated with medicine, compared to 73.5% in those undergoing immunotherapy. Immunotherapy also appears to retard progression from rhinitis to asthma.

Corresponding author

Register with J-STAGE for free!